Companies › ALXO

ALX ONCOLOGY HLDGS INC (ALXO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001810182 · EDGAR filings · Updated 2026-07-27

ALX ONCOLOGY HLDGS INC (ALXO) has reported institutional ownership of 71.6%, with 69 institutional managers holding positions valued at $189.0M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Filings this week (1)

• 2026-07-27 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-06-30 — Current report (8-K) filed
• 2026-06-26 — Current report (8-K) filed
• 2026-06-11 — Current report (8-K) filed
• 2026-05-27 — SCHEDULE 13D/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ALX ONCOLOGY HLDGS INC has 69 institutional holders and institutional ownership of 71.6%.

Insider activity

Insiders reported 13 transactions (4 buys, 8 sells) across 5 reporting insiders, with a net reported value of $5.12M.

Data flags from SEC filings

Related companies

CONTEXT THERAPEUTICS INC (CNTX) · INHIBIKASE THERAPEUTICS INC (IKT) · ALECTOR INC (ALEC) · EVOLUS INC (EOLS) · ARCTURUS THERAPEUTICS HLDGS (ARCT) · AUTOLUS THERAPEUTICS LTD (AUTL)